A GMP protocol for the manufacture of Tregs for clinical application by O'Neil, A, Brook, M, Abdul-Wahab, S, Hester, J, Lombardi, G, Issa, F

“…Infusion of regulatory T cells is a promising therapeutic strategy in organ transplantation to modulate the immune system, prevent rejection, minimize the need for pharmaceutical immunosuppression, and improve long-term transplant outcomes. …”

Muscle Disorders by Hilton-Jones, D

“…The idiopathic inflammatory myopathies, dermatomyositis and polymyositis, respond to immunosuppressant drug therapy. Dermatomyositis may be a paraneoplastic condition and surveillance for cancer is essential. …”

The systemically ill patient by Robson, J, Mistry, A, Bhamra, K, Luqmani, R, Kluzek, S

“…This caution to ensure the correct diagnosis before starting treatment is appropriate; for example, gaining biopsy evidence of systemic vasculitis before starting therapy with steroids or immunosuppressants is important, to avoid inappropriate treatment which may mask or worsen an underlying condition such as tuberculosis or lymphoma. …”